Advisory Services Network’s Ovid Therapeutics OVID Stock Holding History

Advisory Services Network’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$486	Buy	+219	New	+$392	﹤0.01%	4429
2025 Q4	–	Sell	-219	Closed	-$285	–	3509
2025 Q3	$285	Buy	+219	New	+$190	﹤0.01%	4150

Other funds holding OVID

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Advisory Services Network's OVID Position: Q1 2026 in Review

Advisory Services Network opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 219 shares worth $486. The stake represents ﹤0.01% of the portfolio and ranks #4429 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in OVID as recently as Q3 2025.

Advisory Services Network first reported a position in OVID in Q3 2025 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

Advisory Services Network held 219 shares of Ovid Therapeutics worth $486 as of Q1 2026.
Ovid Therapeutics was a new Advisory Services Network position in Q1 2026.
Ovid Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4429 holding.
Advisory Services Network first reported a position in Ovid Therapeutics in Q3 2025 and has held it in 2 quarters since.
103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.